KATHRYN STEELE: Open Payments
NPI 1114228400 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$996 in 12 payments from 9 companies in 2025. Trend: 2023 $566 · 2024 $657 · 2025 $996
Food & beverage: $996
| Company | Payments | Amount |
|---|---|---|
| Tempus AI, Inc | 2 | $244 |
| PFIZER INC. | 2 | $143 |
| Eisai Inc. | 2 | $143 |
| Caris MPI, Inc. | 1 | $121 |
| AstraZeneca Pharmaceuticals LP | 1 | $120 |
| GlaxoSmithKline, LLC. | 1 | $86 |
| Amgen Inc. | 1 | $70 |
| Genmab U.S., Inc. | 1 | $42 |
| Corcept Therapeutics | 1 | $26 |
Products named: XT CDX, Lenvima, MI CANCER SEEK, LYNPARZA, ELREXFIO, REPATHA, Korlym, TIVDAK.
Industry payments across TN — which companies pay providers there.
